← All organizations

Alvotech

For profitWebsite ↗

Also known as: Alvotech Swiss AG | Alvotech USA Inc. | ALVOTECH USA INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Sep 30, 2024

Timeline

2010s

Jan 1, 2013
Alvotech— Founded

2020s

Feb 23, 2024
adalimumab— Marketing Organization

Drugs by trial phase (6 distinct, 16 trials)

Phase 3 (6 own, 0 via acquisition)

Indications

Studied for

Psoriasis

Marketed drugs (2)

Recent trials (20)

NCT06570772Lead sponsorPhase 3Sep 30, 2024
NCT06570772OfficialPhase 3Sep 30, 2024
NCT06400719Lead sponsorPhase 1May 29, 2024
NCT05876949Lead sponsorPhase 1Jul 16, 2023
NCT05876949Study directorPhase 1Jul 16, 2023
NCT05842213Lead sponsorPhase 3Mar 30, 2023
NCT05842213Study directorPhase 3Mar 30, 2023
NCT05632211Lead sponsorPhase 1Nov 21, 2022
NCT05395091Lead sponsorPhase 3Aug 23, 2022
NCT05395091Study directorPhase 3Aug 23, 2022
NCT05155293Lead sponsorPhase 3May 31, 2022
NCT05126784Lead sponsorPhase 1May 30, 2022
NCT04930042Lead sponsorPhase 3Jun 3, 2021
NCT04744363Lead sponsorPhase 1May 25, 2021
NCT04453137Lead sponsorPhase 3Jun 30, 2020

Details

Founded: Reykjavik, IS Jan 1, 2013
Last known activity: Sep 30, 2024